What is the recommended dose of Colistin (polymyxin E) for a patient with normal renal function and severe infection, such as ventilator-associated pneumonia or sepsis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colistin Dosing for Severe Infections with Normal Renal Function

For patients with normal renal function and severe infections such as ventilator-associated pneumonia or sepsis, administer a loading dose of 9 million IU of colistin followed by a maintenance dose of 9 million IU/day divided into 2-3 doses (equivalent to 4.5 million IU every 12 hours). 1, 2, 3

Loading Dose: Critical First Step

The loading dose is non-negotiable and must be given to all patients regardless of renal function 1, 2, 3:

  • Administer 6-9 million IU as a loading dose (9 million IU is preferred for severe infections) 1, 2, 3
  • This is equivalent to approximately 5 mg/kg based on ideal body weight 3, 4
  • The loading dose is essential because colistin has a relatively long half-life, and without it, therapeutic plasma concentrations are not achieved for 2-3 days, leading to suboptimal treatment during the critical early infection period 1, 2
  • Studies in critically ill patients with VAP showed colistin was undetectable in bronchoalveolar lavage at 2 hours after standard dosing without a loading dose 1

Maintenance Dosing

After the loading dose, continue with maintenance therapy 1, 2, 3, 4:

  • 9 million IU/day divided into 2-3 doses (most commonly 4.5 million IU every 12 hours) 1, 2, 3
  • Alternative weight-based dosing: 2.5-5 mg/kg/day divided into 2-4 doses for patients with normal renal function 3, 4
  • For obese patients, calculate dosing based on ideal body weight, not actual body weight 4

Administration Method

Administer as a 4-hour infusion to optimize pharmacokinetic/pharmacodynamic properties 1, 3:

  • This extended infusion may allow treatment of infections involving strains with MIC up to 8 mg/L 1
  • The FDA label also describes direct intermittent administration over 3-5 minutes or continuous infusion options, but the 4-hour infusion is preferred based on PK/PD optimization 1, 4

Critical Dosing Conversions

Understanding colistin dosing units is essential to avoid medication errors 1, 2, 3:

  • 1 million IU of colistin = 80 mg of colistimethate sodium (CMS) 1, 2, 3
  • Colistin is administered as the inactive prodrug CMS, which converts to active colistin in vivo 1, 2, 3
  • The 150 mg vial should be reconstituted with 2 mL Sterile Water for Injection to provide 75 mg/mL colistin base activity 4

Monitoring Requirements

Close monitoring of renal function is mandatory 2, 3:

  • Check renal function at baseline and 2-3 times per week during treatment 2
  • Acute kidney injury during colistin treatment is a major factor related to clinical failure and mortality 2, 5, 3
  • Nephrotoxicity is dose-dependent but usually reversible within one week after discontinuation 5
  • Research shows nephrotoxicity rates of 27-39% with colistin, with higher rates in patients with advanced age or high SOFA scores 6

Common Pitfalls to Avoid

Failure to give a loading dose is the most critical error 1, 2, 7:

  • Approximately one-third to half of patients in clinical practice do not receive a loading dose 7
  • Studies demonstrate that patients receiving a loading dose have significantly better clinical outcomes (55.2% vs 35.8% favorable outcomes at day 14) and microbiological eradication rates (50% vs 27.3%) compared to those without 7
  • The loading dose does not significantly increase nephrotoxicity risk in patients with normal renal function 7

Inadequate dosing for pathogens with higher MICs 8:

  • Standard dosing achieves >90% probability of target attainment only for MIC ≤0.5 μg/mL 8
  • For MIC ≥1 μg/mL, standard dosing poses a risk of subtherapeutic exposure 8
  • Consider combination therapy for organisms with MIC ≥1 mg/L, as colistin monotherapy may be insufficient 9

Alternative: Polymyxin B

Consider polymyxin B as an alternative, particularly in patients at high risk for renal dysfunction 5:

  • Polymyxin B has significantly lower nephrotoxicity (11.8% vs 39.3% with colistin) 5
  • Loading dose: 2-2.5 mg/kg; maintenance: 1.5-3 mg/kg/day in 2 doses 1, 5
  • Unlike colistin, polymyxin B is administered as the active drug and plasma concentrations are not influenced by renal function 1, 5
  • No dose adjustment needed for continuous renal replacement therapy 1, 5

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.